Tareq Abadl: Anemia of Inflammation – Hepcidin Regulation of Iron
Tareq Abadl, Medical Laboratory Specialist and Director of the Blood Bank at Dr. Abdelkader Al-Mutawakkil Hospital, shared a post on LinkedIn:
“Hepcidin – the iron gatekeeper
When hepcidin is high – serum iron and transferrin saturation (TSAT) are decreased — even if total body iron stores are normal.
This is the central mechanism behind anemia of inflammation (functional iron deficiency).
Why laboratories should care
1. Diagnostic power
Hepcidin measurement strengthens the differential diagnosis of anemia:
- Low hepcidin – true iron-deficiency anemia (IDA)
- High or normal hepcidin – anemia of chronic disease (ACD)/functional iron deficiency
This distinction directly determines whether oral iron therapy will succeed or fail.
Recent reviews and cohort studies consistently support hepcidin as a valuable adjunct marker in complex anemia workups.
2.Therapeutic prediction
Elevated hepcidin predicts poor response to oral iron.
It may guide clinicians toward:
- IV iron therapy
- Anti-inflammatory strategies
- CKD-specific management pathways
Assays — What Labs Must Know Before Implementation
Two main methodologies:
1. LC-MS/MS (Mass Spectrometry)
- High specificity
- Better harmonization potential
- Considered reference-grade
2. Immunoassays
- Convenient and commercially available
- Tend to read higher than MS methods
- Greater inter-platform variability, especially in inflammatory states
Do not mix values from different platforms. Know exactly which method your lab is using.
Standardization status
Harmonization is improving – but not perfect.
Proficiency testing shows inter – method variability.
Before offering clinical reporting:
- Perform method comparison with a reference lab
- Participate in external quality assessment (EQA) programs
- Establish internal QC material
Pre-analytical and reporting essentials
Proper pre-analytics are critical for reliable results:
- Use validated specimen type (EDTA plasma vs serum – assay dependent)
- Control time – to – centrifugation
- Avoid hemolysis
- Aliquot promptly
- Store at −80 degrees Celsius for batch analysis
Every report must include:
- Specimen type
- Analytical method
- Reference interval
Clinical interpretation without these details is risky.
Clinical interpretation framework
- Low hepcidin plus low ferritin plus low TSAT
True iron deficiency
Oral iron usually appropriate - High/normal hepcidin plus low TSAT plus normal/high ferritin
Functional iron sequestration (inflammation, CKD)
Consider IV iron or treat underlying inflammation
Oral iron likely ineffective - Borderline cases
Interpret alongside:
- Ferritin
- CRP
- TSAT
Clinical context (infection, CKD, pregnancy, recent transfusion)
Practical rollout checklist for laboratories
- Define the clinical use case (diagnostic reflex? research? clinician-requested test?)
- Select assay method
- Perform method comparison vs reference lab
- Finalize pre-analytical SOPs
- Train phlebotomy and processing staff
- Implement internal QC plus enroll in proficiency testing
- Add LIS interpretative comments to guide clinicians.”

Other posts featuring Tareq Abadl on Hemostasis Today.
-
Apr 27, 2026, 07:08Jeff Schaffnit: Global Voices in Hemophilia Care at the World Federation of Hemophilia World Congress
-
Apr 27, 2026, 06:44Andrew M. Evens: Award-Winning Research from the British Society for Haematology 66th Annual Meeting
-
Apr 27, 2026, 05:19Harshal Kale: Celebrating Hemophilia Partnerships on a Global Stage
-
Apr 26, 2026, 17:17Ajigbotosho Barakat: Leg Strength as a Key to Healthy Aging
-
Apr 26, 2026, 17:02Francisco Chacón-Lozsán: Limited Evidence Methylene Blue in Vasoplegic Shock
-
Apr 26, 2026, 16:57Gopal Patidar: Key Areas of Haemovigilance in ISBT Transfusion Today
-
Apr 26, 2026, 16:56Cathy Harrison: Oral Health in Older Adults Assessing the Impact of Ageing, Heart Failure, and Social Isolation
-
Apr 26, 2026, 15:08Andreas Ejlegård: Rebalancing Thrombosis and Hemostasis Through Mechanistic Innovation
-
Apr 26, 2026, 14:55Vanessa Simioni Faria: Precision Anticoagulation and Expanding Donor Frontiers